Lapatinib Ditosylate CAS 388082-78-8

Khoom Piav Qhia:

Khoom Lub Npe: Lapatinib ditosylate CAS TSIS TAU: 388082-78-8

Lub ntsiab lus:

N- (3-Chloro-4-((3-fluorophenyl) methoxy) phenyl) -6- (5-(((2- (methylsulfonyl) ethyl) amino) methyl) -2-furanyl) -4-quinazolinamine bis ( 4-methylbenzenesulfonate) monohydrate;

Lapatinib ditosylate hydrate;

Lapatinib ditosylate Monohydrate;

Tshuaj& Lub Cev Muaj Zog:

Tshwm sim: Tsis muaj xim rau lub teeb daj daj

Kev Ntsuas: ≥99.00%

Ceev: 1.403 g/mL (20.84 ℃)

Kub Point: 750.7 ℃ ntawm 760 mmHg

Melting Point: 237 - 239 ℃

Flash Point: 407.8 ℃

Refractive Index: n20/D 1.5520 (lit.)

Cov Ntaub Ntawv Kev Nyab Xeeb:

Cov Lus Hais Txog Kev Nyab Xeeb: S24; S37; S61

Cov nqe lus pheej hmoo: R43; R51/53

Cov lej phom sij: Xi; N

Lapatinib (INN), siv nyob rau hauv daim ntawv ntawm lapatinib ditosylate, (USAN) (Tykerb/Tyverb, GSK) yog cov tshuaj nquag hais lus rau mob qog noj ntshav thiab lwm yam qog nqaij hlav. Nws yog ob qho tib si tyrosine kinase inhibitor uas cuam tshuam HER2/neu thiab epidermal growth factor receptor (EGFR) txoj hauv kev. Nws tau siv ua ke kho mob HER2-positive mob qog noj ntshav. Nws yog siv rau kev kho mob ntawm cov neeg mob uas muaj mob qog noj ntshav lossis mob qog noj ntshav loj heev uas nws cov qog nqaij hlav ntau dhau HER2 (ErbB2).

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.

Cim npe nrov: lapatinib ditosylate cas 388082-78-8, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

• Tug: 5- [4-((3-Chloro-4-((3-fluorobenzyl) oxy] phenyl) amino) quinazolin-6-yl] -2-furaldehyde CAS 231278-84-5
• Tom ntej: N- (5-Amino-2-methylphenyl) -4- (3-pyridyl) -2-pyrimidineamine CAS 152460-10-1